메뉴 건너뛰기




Volumn 108, Issue 7, 2008, Pages 23-26

The use of dipyridamole (curantyl) in combination with α-lipoic acid in the treatment of diabetic neuropathy with retinopathy

(1)  Al Zamil, M Kh a  

a NONE

Author keywords

Curantyl; Diabetic neuropathy; Diabetic retinopathy; lipoic acid (berlition)

Indexed keywords


EID: 49749132007     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (3)

References (13)
  • 1
    • 49749102803 scopus 로고    scopus 로고
    • Russian source
    • Russian source
  • 2
    • 49749133921 scopus 로고    scopus 로고
    • Russian source
    • Russian source
  • 3
    • 0031752714 scopus 로고    scopus 로고
    • Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group
    • Apfel S.C. et al. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group. Neurology 1998; 51: 3: 695-702.
    • (1998) Neurology , vol.51 , Issue.3 , pp. 695-702
    • Apfel, S.C.1
  • 4
    • 0345599006 scopus 로고    scopus 로고
    • Laminin 1 is critical for Schwann cell differentiation, axon myelination, and regeneration in the peripheral nerve
    • Chen Z.L. et al. Laminin 1 is critical for Schwann cell differentiation, axon myelination, and regeneration in the peripheral nerve. J Cell Biol 2003; 163: 889-899.
    • (2003) J Cell Biol , vol.163 , pp. 889-899
    • Chen, Z.L.1
  • 5
    • 0030297319 scopus 로고    scopus 로고
    • European Stroke Prevention Study 2: Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke
    • Diener H.C., Cunha L., Forbes C. et al. European Stroke Prevention Study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143: 1-13.
    • (1996) J Neurol Sci , vol.143 , pp. 1-13
    • Diener, H.C.1    Cunha, L.2    Forbes, C.3
  • 6
    • 49749123877 scopus 로고    scopus 로고
    • Dyck P.J., Dyck P.J.B. Diabetic polyneuropathy: section III. In: Diabetic Neuropathy. 2-nd ed. P.J. Dyck, P.K. Thomas (eds.). Philadelphia 1999; 255-278.
    • Dyck P.J., Dyck P.J.B. Diabetic polyneuropathy: section III. In: Diabetic Neuropathy. 2-nd ed. P.J. Dyck, P.K. Thomas (eds.). Philadelphia 1999; 255-278.
  • 7
    • 0019161221 scopus 로고
    • Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry
    • Dyck P.J., Sherman W.R., Hallcher L.M. et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 1980; 8: 590-596.
    • (1980) Ann Neurol , vol.8 , pp. 590-596
    • Dyck, P.J.1    Sherman, W.R.2    Hallcher, L.M.3
  • 8
    • 0029929238 scopus 로고    scopus 로고
    • Diabetes and the nervous system
    • Harati Y. Diabetes and the nervous system. Endocrinol Metab Clin North Am 1996; 25: 2: 325-359.
    • (1996) Endocrinol Metab Clin North Am , vol.25 , Issue.2 , pp. 325-359
    • Harati, Y.1
  • 9
    • 0038497913 scopus 로고    scopus 로고
    • Effects of Proinsulin C-Peptide in Experimental Diabetic Neuropathy. Vascular Actions and Modulation by Nitric Oxide Synthase Inhibition
    • Mary A. et al. Effects of Proinsulin C-Peptide in Experimental Diabetic Neuropathy. Vascular Actions and Modulation by Nitric Oxide Synthase Inhibition. Diabetes 2003; 52: 1812-1817.
    • (2003) Diabetes , vol.52 , pp. 1812-1817
    • Mary, A.1
  • 10
    • 3943108900 scopus 로고    scopus 로고
    • Cohen. Diabetic Vascular Disease: Pathophysiological Mechanisms in the Diabetic Milieu and Therapeutic Implications
    • Richard A. Cohen. Diabetic Vascular Disease: Pathophysiological Mechanisms in the Diabetic Milieu and Therapeutic Implications. Arteriosclerosis, Thrombosis, and Vascular Biology 2004; 24: 1340.
    • (2004) Arteriosclerosis, Thrombosis, and Vascular Biology , vol.24 , pp. 1340
    • Richard, A.1
  • 11
    • 18144436151 scopus 로고    scopus 로고
    • Characterisation of autoantibodies to peripheral myelin protein 22 in patients with hereditary and acquired neuropathies.
    • Ritz M.F. et al. Characterisation of autoantibodies to peripheral myelin protein 22 in patients with hereditary and acquired neuropathies. : J Neuroimmunol 2000; 104: 2: 155-163.
    • (2000) J Neuroimmunol , vol.104 , Issue.2 , pp. 155-163
    • Ritz, M.F.1
  • 12
    • 49749109127 scopus 로고
    • Diabetes collaboration study group. Suggested intervention strategy for early complications of diabetes mellitus
    • Srikanta S.S. et al. Diabetes collaboration study group. Suggested intervention strategy for early complications of diabetes mellitus. Int J Diab Dev Countries 1992; 2.
    • (1992) Int J Diab Dev Countries , pp. 2
    • Srikanta, S.S.1
  • 13
    • 34547692894 scopus 로고    scopus 로고
    • Pathology and pathogenetic mechanisms of diabetic neuropathy: Correlation with clinical signs and symptoms
    • Yagihashi S. et al. Pathology and pathogenetic mechanisms of diabetic neuropathy: correlation with clinical signs and symptoms. Diabetes Res Clin Pract 2007; 77: Suppl 1: 184-189.
    • (2007) Diabetes Res Clin Pract , vol.77 , Issue.SUPPL. 1 , pp. 184-189
    • Yagihashi, S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.